AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications

Updated: Jan 12

"Mr. Anthony Hayes, CEO of AIkido, stated, "We are excited to explore this aspect of cancer treatment. Our license covers the use of psilocybin to treat both cancer and cancer side-effects and we believe this to be an expanding area for treatment."

010721 AIkido Pharma Inc
. Executes Licen
Download EXECUTES LICEN • 61KB

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC